Vext Science, Inc. (OTC:VEXTF) is a U.S.-based cannabis operator with operations in Arizona and Ohio. The company focuses on expanding its retail presence and capitalizing on the growing cannabis market. Vext competes with other cannabis operators in the region, aiming to strengthen its market position through strategic expansions and operational improvements.
On November 20, 2025, Vext reported an earnings per share (EPS) of -$0.01, which was below the estimated EPS of -$0.0085. The company generated a revenue of $12.67 million, falling short of the estimated $14.62 million. Despite this, Vext achieved a 41% revenue increase compared to the same period last year, driven by retail expansion in Ohio and strong performance in Arizona.
Vext issued a corrected press release for its Q3 2025 financial results, addressing inaccuracies in reconciling items between net earnings, EBITDA, and Adjusted EBITDA. This correction ensures accurate financial information for the period ending September 30, 2025. The company's Q3 earnings call featured key participants, including CEO Eric Offenberger and CFO Trevor Smith, along with financial analysts.
The company's financial metrics reveal a price-to-earnings (P/E) ratio of -2.74, indicating negative earnings. The price-to-sales ratio is 1.02, suggesting investors pay $1.02 for every dollar of sales. The enterprise value to sales ratio is 1.72, and the enterprise value to operating cash flow ratio is 6.90, reflecting the company's valuation relative to sales and cash flow.
Vext's debt-to-equity ratio is 0.50, indicating moderate debt levels compared to equity. The current ratio is 0.94, suggesting slightly less liquidity to cover short-term liabilities. Despite these challenges, Vext's strategic expansion in Ohio, aiming to reach the state's dispensary license cap by 2026, positions the company for future growth in the adult-use cannabis market.
